David Seftel
Impact in
- Biological Psychiatry top 10%
- Tryptophan and brain disorders
- Infectious Diseases top 10%
- SARS-CoV-2 and COVID-19 Research
- SARS-CoV-2 detection and testing
- COVID-19 Clinical Research Studies
Papers in
-
- SARS-CoV-2 and COVID-19 Research 6
- SARS-CoV-2 detection and testing 5
- COVID-19 Clinical Research Studies 2
- Genetics 7
- Diabetes and associated disorders 7
- Co-authors
- David R. Boulware (1 shared paper)Peter V. Robinson (8 shared papers)Cheng‐ting Tsai (12 shared papers)Felipe de Jesus Cortez (6 shared papers)Mark Pandori (2 shared papers)Carolyn R. Bertozzi (2 shared papers)Kevin Miller (2 shared papers)Sean J. Pittock (1 shared paper)
- Journals
- SLAS TECHNOLOGY (2 papers)Open Forum Infectious Diseases (2 papers)Transfusion (1 paper)Frontiers in Endocrinology (1 paper)Pediatric Diabetes (1 paper)
- Partner nations
- United StatesSwedenItaly
In The Last Decade
David Seftel
15 papers receiving 282 citations
Peers
Comparison fields: 5 of 70
- Biological Psychiatry 43
- Infectious Diseases 116
- Neurology 61
- Endocrinology, Diabetes and Metabolism 44
- Genetics 56
Countries citing papers authored by David Seftel
This map shows the geographic impact of David Seftel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Seftel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Seftel more than expected).
Fields of papers citing papers by David Seftel
This network shows the impact of papers produced by David Seftel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Seftel. The network helps show where David Seftel may publish in the future.
Co-authors
The 25 scholars most cited alongside David Seftel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 106 | |
| 2 | 2020 | 47 | |
| 3 | 2018 | 33 | |
| 4 | 2020 | 30 | |
| 5 | 2020 | 21 | |
| 6 | 2022 | 19 | |
| 7 | 2022 | 10 | |
| 8 | 2021 | 10 | |
| 9 | 2022 | 8 | |
| 10 | 2022 | 3 | |
| 11 | AIDS and apartheid: double trouble. | 2000 | 3 |
| 12 | 2024 | 2 | |
| 13 | 2025 | 1 | |
| 14 | 2024 | 1 | |
| 15 | 2024 | 1 | |
| 16 | 2025 | 0 |
About David Seftel
David Seftel is a scholar working on Infectious Diseases, Genetics, Surgery, Endocrinology, Diabetes and Metabolism and Molecular Biology, having authored 16 papers that have together received 295 indexed citations. Recurring topics across this work include Diabetes and associated disorders (7 papers), SARS-CoV-2 and COVID-19 Research (6 papers), Pancreatic function and diabetes (5 papers), Diabetes Management and Research (5 papers), SARS-CoV-2 detection and testing (5 papers), Biosensors and Analytical Detection (2 papers), COVID-19 Clinical Research Studies (2 papers) and HIV Research and Treatment (1 paper). The work is most often cited by research in Biological Psychiatry (43 citations), Infectious Diseases (116 citations), Neurology (61 citations), Endocrinology, Diabetes and Metabolism (44 citations) and Genetics (56 citations). David Seftel has collaborated with scholars based in United States, Sweden and Italy. Frequent co-authors include David R. Boulware, Peter V. Robinson, Cheng‐ting Tsai, Felipe de Jesus Cortez, Mark Pandori, Carolyn R. Bertozzi, Kevin Miller, Sean J. Pittock, Wendy A. Wolf and Matthew M. Roforth. Their work appears in journals such as SLAS TECHNOLOGY, Open Forum Infectious Diseases, Transfusion, Frontiers in Endocrinology and Pediatric Diabetes.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.